Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 23,209 shares at $25.30 ($587K) on 2022-03-09, disclosed to the SEC on 2022-03-11.
Scheduled sale ($587k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.30 | 23,008 | $582K | 99.1% |
| 2 | $26.02 | 201 | $5K | 0.9% |
| Total | $25.31 avg | 23,209 | $587K | 100% |
| Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |
| HCAT | SELL | 2021-12-29 | $183K | — | Filing → |